Skip to main content
By HIMSS TV | 05:00 am | September 25, 2020
Telehealth became a service that required a "clinical champion" to a necessary part of Yale New Haven Health Services' offerings, says Dr. Pam Hoffman, medical director of telehealth services at the health system.
By HIMSS TV | 05:05 pm | September 22, 2020
The digital health indicator has enabled a more integrated, outcomes-orientated healthcare system, says Vanessa Janissen, national director of strategy and service development at Calvary Health Care in Australia.
By HIMSS TV | 06:00 pm | September 15, 2020
Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the need for regulatory "agility" during the COVID-19 pandemic.
By HIMSS TV | 09:26 am | July 17, 2020
HealthEC is able to identify the top 10% of a client's patients who are at highest risk for a severe outcome due to COVID-19, says Dr. Jenifer Leaf Jaeger, the company's senior medical director.
By HIMSS TV | 06:43 am | July 15, 2020
Tia cofounder and CEO Carolyn Witte discusses the growing world of "femtech" and what it means to run a startup during the coronavirus pandemic.
By HIMSS TV | 08:01 am | July 07, 2020
Not only must the front door be easy to open, it must extend beyond the system's website to search engines and guided interactions like text and chat, say Erin Jospe, MD, chief medical officer at Kyruus, and AVIA VP Sonia Singh.
By HIMSS TV | 07:00 am | June 26, 2020
Co-producer Kate Milliken tells how the online community she started for other folks living with multiple sclerosis grew into her new short film, "Beneath the Surface."
By HIMSS TV | 08:19 am | June 17, 2020
Virtual care may be the way of the future for treating diabetes, says Julia Hu, founder and CEO of Lark Health.
By HIMSS TV | 09:12 am | June 15, 2020
Gail MacKean, a founding member of IMAGINE Citizens Collaborating for Health, discusses the history of patient- and family-centric care and why it's important to include diverse voices.
By HIMSS TV | 10:03 am | June 12, 2020
First Databank has adjusted its own editorial practices as evidence of COVID-19 drugs and treatment continues to evolve, says Anna Dover, the company's director of product management.